A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer’s disease, as well as existing drugs that have therapeutic potential against these targets.
Blood test can predict presence of beta-amyloid in the brain, new study finds (Links to an external site)
![](https://knightadrc.wustl.edu/app/uploads/2022/02/biomarkers-alzheimers-blood-300x200.jpg)